A Non-Coding RNA Balancing Act: miR-346-Induced DNA Damage Is Limited by the Long Non-Coding RNA NORAD in Prostate Cancer

miR-346 could be particularly effective as a therapeutic in the context of decreased NORAD observed in advanced prostate cancer, and in transcriptionally-hyperactive cancer cells.